78 results
Page 2 of 4
424B3
pcuce2eqv ube
15 Jul 21
Prospectus supplement
4:45pm
S-4/A
ciey5f lwsy4ppgmvf
13 Jul 21
Registration of securities issued in business combination transactions (amended)
4:41pm
S-4
1q67uhit3
1 Jul 21
Registration of securities issued in business combination transactions
12:00am
8-K
EX-2.1
8mov6
7 May 21
Entry into a Material Definitive Agreement
7:09am
425
EX-2.1
ke926721dt
7 May 21
Business combination disclosure
7:08am
DEF 14A
t1fvd6nv0r7k biys
9 Sep 20
Definitive proxy
4:00pm
10-Q
4unxn9a6
13 Aug 20
Quarterly report
8:30am
PRE 14A
48es19hz8il1jo2
10 Aug 20
Preliminary proxy
12:00am
10-K
pohqysk8
29 Jun 20
Annual report
4:02pm
S-3
EX-1.2
y8v4qu
29 Jun 20
Shelf registration
12:00am
6-K
EX-99.1
yhj9mymk
14 Feb 20
Acasti Pharma Provides Business Update for the Third Quarter of Fiscal 2020
8:00am
6-K
EX-99.1
0zynb2qrg nusp98ljk
14 Feb 20
Current report (foreign)
8:00am
6-K
EX-99.1
mhhogql
10 Feb 20
Acasti Pharma Provides Update on TRILOGY 1 and TRILOGY 2 Phase 3 Trials of CaPre
7:00am
6-K
EX-99.1
dkowcb
13 Jan 20
Acasti Pharma Reports Topline Results for TRILOGY 1 Phase 3 Trial of CaPre
6:21am
6-K
EX-99.1
hqznaklcukvkws3
13 Nov 19
Current report (foreign)
7:55am